Ischemic heart disease—major cause of death and graft loss after renal transplantation in scandinavia

Transplantation

Volumn 60, Issue 5, 1995, Pages 451-457

  Lindholm, Anders ^a   Albrechtsen, Dagfinn ^b   Frödin, Lars ^c   Tufveson, Gunnar ^d   Persson, Nils H ^e   Lundgren, Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CADAVER DONOR; CAUSE OF DEATH; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; GENDER; GRAFT SURVIVAL; HEART INFARCTION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCANDINAVIA;

ADULT; AGE FACTORS; AGED; CAUSE OF DEATH; DIABETIC NEPHROPATHIES; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 0029144535     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199509000-00008     Document Type: Article

References (23)

1. Caine RY, White DJG, Thiru S, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978; 2: 1323.
2. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725.
3. Higgins RM, Bloom SL, Hopkin JM, Morris PJ. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation 1989; 47: 558.
4. Pettersson E, Hovi T, Ahonen J, et al. Prophylactic oral acyclovir after renal transplantation. Transplantation 1985; 39: 279.
5. Dunn J, Golden D, van Buren CT, Lewis RM, Lawen J, Kahan BD. Causes of graft loss beyond two years in the cyclosporine era. Transplantation 1990; 49: 349.
6. Hong JH, Sumrani N, Delaney V, Davis R, Dibenedetto A, Butt KMH. Causes of late renal allograft failure in the ciclosporin era. Nephron 1992; 62: 272.
7. Lindholm A, Albrechtsen D, Tutveson G, Karlberg I, Persson NH, Groth CG. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine and prednisolone in primary cadaveric renal transplantation. Transplantation 1992; 54; 624.
8. Lindholm A, Ohlman S, Albrechtsen D, Tufveson G, Persson H, Persson NH. The impact of acute rejection episodes on longterm graft function and outcome in 1347 primary renal transplants treated by three cyclosporine regimens. Transplantation 1993; 56: 307.
9. Lindholm A, Albrechtsen D, Flatmark A, et al. A randomized multicenter trial of cyclosporin and prednisolone versus cyclosporin, azathioprine, and prednisolone following primary living donor renal transplantation. Transplant Int 1994; 7: 207.
10. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988; 84: 985.
11. Curtis JJ. Hypertension and kidney transplantation. Am J Kidney Dis 1986; 7: 181.
12. Chan MK, Varghese Z, Moorhead JF. Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int 1981; 19: 625.
13. World Health Organization. World Health Organization statis tics annual 1987. Geneva: WHO, 1988.
14. Fassbinder W, Brunner FP, Brynger H, et al. Combined report of regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 1991: 6 (suppl 1): 5.
15. Lundgren G, Groth CG, Albrechtsen D, et al. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation-a changing picture with cyclosporin. Lancet 1986; 2: 66.
16. Donatsch P, Abisch E, Homberger M, Traber R, Trapp M, Voges R. A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay 1981; 2: 19.
17. Statistiska Centralbyrån. Statistisk årsbok 1992. Stockholm: Statistiska Centralbyrån, 1992.
18. Cox DR, Oates D. Analysis of survival data. London: Chapman and Hall, 1984.
19. Brunner FP, Selwood NH. Profile of patients on RRT in Europe and death rates due to major causes of death groups. Kidney Int 1992; 42 (suppl 38): S4.
20. Rao KV, Andersen RC. Long-term results and complications in renal transplant recipients: observations in the second decade. Transplantation 1988; 45: 45.
21. National Institute of Diabetes and Digestive and Kidney Diseases. United States renal disease data system: 1991 report (NIH publication 91-3176). Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 1991: E39.
22. Houston MC, Dzau VJ. Hypertension as a risk factor. In: Loscalzo J, Creager MA, Dzau VJ, eds. Vascular medicine. 1992: 621.
23. Fischel RJ, Rayne WD, Gillingham KJ, et al. Long-term outlook for renal transplant recipients with one-year function. Transplantation 1991; 51: 118.